Slansky JE - Search Results

1

Peptide Centric Vβ Specific Germline Contacts Shape a Specialist T Cell Response.

Wang Y, Tsitsiklis A, Devoe S, Gao W, Chu HH, Zhang Y, Li W, Wong WK, Deane CM, Neau D, Slansky JE, Thomas PG, Robey EA, Dai S. Wang Y, et al. Among authors: slansky je. Front Immunol. 2022 Jul 29;13:847092. doi: 10.3389/fimmu.2022.847092. eCollection 2022. Front Immunol. 2022. PMID: 35967379 Free PMC article.

2

Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.

Jordan KR, McMahan RH, Oh JZ, Pipeling MR, Pardoll DM, Kedl RM, Kappler JW, Slansky JE. Jordan KR, et al. Among authors: slansky je. J Immunol. 2008 Jan 1;180(1):188-97. doi: 10.4049/jimmunol.180.1.188. J Immunol. 2008. PMID: 18097019 Free PMC article.

3

Peptide mimotopes alter T cell function in cancer and autoimmunity.

Slansky JE, Nakayama M. Slansky JE, et al. Semin Immunol. 2020 Feb;47:101395. doi: 10.1016/j.smim.2020.101395. Epub 2020 Mar 20. Semin Immunol. 2020. PMID: 32205022 Free PMC article. Review.

4

T-cell receptor affinity in the age of cancer immunotherapy.

Hoffmann MM, Slansky JE. Hoffmann MM, et al. Among authors: slansky je. Mol Carcinog. 2020 Jul;59(7):862-870. doi: 10.1002/mc.23212. Epub 2020 May 9. Mol Carcinog. 2020. PMID: 32386086 Free PMC article. Review.

5

Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer.

Wei P, Jordan KR, Buhrman JD, Lei J, Deng H, Marrack P, Dai S, Kappler JW, Slansky JE, Yin L. Wei P, et al. Among authors: slansky je. Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):e2100588118. doi: 10.1073/pnas.2100588118. Proc Natl Acad Sci U S A. 2021. PMID: 34074778 Free PMC article.

6

Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.

McMahan RH, McWilliams JA, Jordan KR, Dow SW, Wilson DB, Slansky JE. McMahan RH, et al. Among authors: slansky je. J Clin Invest. 2006 Sep;116(9):2543-51. doi: 10.1172/JCI26936. Epub 2006 Aug 24. J Clin Invest. 2006. PMID: 16932807 Free PMC article.

7

Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.

Jordan KR, McMahan RH, Kemmler CB, Kappler JW, Slansky JE. Jordan KR, et al. Among authors: slansky je. Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4652-7. doi: 10.1073/pnas.0914879107. Epub 2010 Jan 26. Proc Natl Acad Sci U S A. 2010. PMID: 20133772 Free PMC article.

8

Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses.

Kemmler CB, Clambey ET, Kedl RM, Slansky JE. Kemmler CB, et al. Among authors: slansky je. J Immunol. 2011 Nov 1;187(9):4431-9. doi: 10.4049/jimmunol.1101555. Epub 2011 Sep 21. J Immunol. 2011. PMID: 21940675 Free PMC article.

9

Improving T cell responses to modified peptides in tumor vaccines.

Buhrman JD, Slansky JE. Buhrman JD, et al. Among authors: slansky je. Immunol Res. 2013 Mar;55(1-3):34-47. doi: 10.1007/s12026-012-8348-9. Immunol Res. 2013. PMID: 22936035 Free PMC article. Review.

10

Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.

Buhrman JD, Jordan KR, Munson DJ, Moore BL, Kappler JW, Slansky JE. Buhrman JD, et al. Among authors: slansky je. J Biol Chem. 2013 Nov 15;288(46):33213-25. doi: 10.1074/jbc.M113.509554. Epub 2013 Oct 8. J Biol Chem. 2013. PMID: 24106273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters